Searched for
WARNER LAMBERT
Metsera accepts Pfizer's $10 billion bid in ongoing M&A battleMetsera has accepted Pfizer's $10 billion acquisition offer. This ends a bidding war with rival Novo Nordisk. Pfizer will pay $86.25 per sh...- Namit Malhotra’s DNEG wins its eighth Oscar for Dune: Part Two in the VFX categoryDNEG won its eighth Visual Effects Oscar for its work on Dune: Part Two at the 97th Academy Awards. CEO Namit Malhotra thanked the team and...
- Junk bonds and market cycles: Lessons for today's investorsThe legacy of Michael Milken and his junk bonds continues to persist with today's US junk loan market standing at $1.4tn. The HYB market is...
- Disney names Mahesh Samat APAC head of Consumer Products CommercializationThe move comes ahead of merger of 21st Century Fox’ assets that may see reshuffle at the top level.
- Change of guard at ITC’s lifestyle armThe change comes at a time when the company is making a strategic shift —people in the know said ITC is trying to make John Players an onli...
- Mahesh Samat returns to Disney India as Managing Director after four yearsAditya Pittie of Pittie Group joined the company as director to lead the day-to-day operations of the channel, paving the way for Samat to ...
- Pfizer to reportedly sign a deal to buy Allergan for $150 billion; to be drug industry's biggest dealUS drug giant Pfizer is reportedly moving closer to sign a deal to buy Botox maker Allergan for $150 billion, or about Rs 9,88,000 crore.
- Pfizer, allergan in talks to forge $330bn giant: WSJA bid for Allergan would be Pfizer's second attempt to acquire a European rival, following its unsuccessfully courtship of AstraZeneca Plc.
- AB InBev-SABMiller merger would be among largest in corporate historyIf completed, the deal would rank as one of the world's biggest takeovers:
- Pfizer pledges to ringfence drug development in AstraZeneca dealAstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.
- Best companies to work for 2013: HR's biggest dilemma is to reinvent itself, says Preethi Madappa, IntelTo date, career human resources professionals have done a good job at HR. They bring the right knowledge, tools and concepts to the job.
- Unfair practices: Pharma cos GlaxoSmithkline, Pfizer, Johnson & Johnson and others fined $13 bn in 4 yearsGlaxoSmithkline, Pfizer, Johnson & Johnson, AstraZeneca, Merck, Abbot, Eli Lilly and Allergen have paid about $13 billion in fines to settl...
- Pfizer deal buzz lifts Biocon to 52-wk highBiocon surged on buzz that Pfizer is in talks to buy a stake or strike a marketing alliance with it.
- Pfizer may go all out for RanbaxyA rumoured counter-bid by Pfizer for Ranbaxy is eerily similar to the US firm’s actions in November 1999 when it launched an aggressive bid...
- New study adds to worries about diabetes drug classAnother study has found that diabetes drugs intended to help patients live longer, healthier lives may in fact increase the chances they wi...
- Ranbaxy partially wins over Lipitor patentIn a partial win for country's biggest drugmaker Ranbaxy Laboratories in the ongoing patent litigation with Pfizer over atorvastatin (Lipit...
- Warner, Universal, Viacom bid for BMGWarner Music Group, Universal Music Group and Viacom have made bids for BMG Music Publishing, a unit of German media giant Bertelsmann, a l...
- Ex-Credit Suisse banker strikes pact with US legal eaglesFormer Credit Suisse Group investment banker Frank Quattrone reached an agreement with US prosecutors that may lead to dismissal of crimina...
- UK court rejects Ranbaxy's appeal against drug patentIn a setback to country's biggest drug maker Ranbaxy Laboratories, the UK Court of Appeal has upheld an earlier ruling by the UK High Court...
- Nod to Rs 58.50-cr proposal of CDP MediaNEW DELHI: The government on Thursday cleared the Rs 58.50-crore proposal of Mauritius-based company CDP Media Holdings for 100 per cent eq...
Load More
